Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Obama to meet lawmakers in attempt to protect health law: Politico

President Barack Obama plans to meet with Democratic lawmakers in Congress to discuss how to protect his signature healthcare law from Republican efforts to dismantle it, Politico reported.

Read More »

More work lies ahead to fight Zika, other threats: CDC chief

A year ago, the mosquito-borne Zika virus was only beginning to reveal itself as a threat to pregnant women and their unborn babies. Since then, U.S. officials have issued 60 travel alerts along with guidance for athletes and tourists traveling to the Olympics in Rio. They have also deployed more than 1,000 experts to Puerto Rico and elsewhere, tested more than 147,000 lab specimens, initiated 25 major studies and issued more than 230 scientific publications. And the work is not done, said Dr. Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention.

Read More »

Growth hormone deficiency drug fails study

OPKO Health Inc. said its experimental drug for GHD in adults failed to provide a statistically significant benefit over a placebo in a late-stage study.

Read More »

Dietary magnesium tied to lower risk of heart disease and diabetes

A diet rich in magnesium – found in foods like leafy greens, fish, nuts and whole grains – may help lower the risk of chronic health problems like heart disease and diabetes, a research review suggests.

Read More »

7 Juicy Acquisition Targets in Biopharma for 2017

2016 was not a banner year for M&A in the biopharma industry compared to 2014 and 2015. BioPharmaDIVE looks at seven potential acquisition targets for 2017.

Read More »

Innocoll Shares Tumble After FDA’s Refusal to File Xaracoll NDA

Innocoll received a Refusal to File letter from the United States Food and Drug Administration (FDA) for XARACOLL, the company’s product candidate for the treatment of postsurgical pain.

Read More »

“Hidden’ celiac disease less common now in U.S.

Fewer people in the U.S. have celiac disease without realizing it, a new study finds.

Read More »

Web-based therapy relieves insomnia

Web-based therapy for insomnia is an effective option that could reach “previously unimaginable numbers of people,” researchers suggest.

Read More »

FDA rejects Cempra’s antibiotic for pneumonia

The FDA rejected Cempra Inc.’s antibiotic for community-acquired bacterial pneumonia, citing inadequate data on the drug’s impact on liver and manufacturing issues.

Read More »

Like It or Not: Here’s How Much Biogen’s Spinraza Will Cost

Biogen finally set a price tag for its newly approved spinal atrophy drug Spinraza – the first drug ever approved for the disease – and as expected, it’s in the high six figures.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom